{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:54:57Z","timestamp":1794246897126,"version":"4.9.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI164947-03S2"],"award-info":[{"award-number":["R01AI164947-03S2"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["38920-6"],"award-info":[{"award-number":["38920-6"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.annepidem.2025.11.006","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T16:05:30Z","timestamp":1764086730000},"page":"13-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Impact of integrase strand transfer inhibitors on cardiovascular disease in people with HIV"],"prefix":"10.1016","volume":"113","author":[{"given":"Buwei","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bankole","family":"Olatosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2025.11.006_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.7326\/0003-4819-137-5_Part_2-200209031-00001","article-title":"Guidelines for using antiretroviral agents among HIV-infected adults and adolescents: the panel on clinical practices for treatment of HIV*","volume":"137","author":"Dybul","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annepidem.2025.11.006_bib2","series-title":"Testing, treatment, service delivery and monitoring: recommendations for a public health approach","author":"Consolidated Guidelines on HIV Prevention","year":"2021"},{"key":"10.1016\/j.annepidem.2025.11.006_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/v13020205","article-title":"Integrase strand transfer inhibitors are effective anti-HIV drugs","volume":"13","author":"Smith","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.annepidem.2025.11.006_bib4","unstructured":"HIV.Gov What to Start: Integrase Strand Transfer Inhibitor Regimens n.d. \u3008https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/what-start-integrase-strand-transfer\u3009 (accessed February 23, 2025)."},{"key":"10.1016\/j.annepidem.2025.11.006_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/hiv.12440","article-title":"Switching regimens in virologically suppressed HIV -1\u2013infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimens","volume":"17","author":"Raffi","year":"2016","journal-title":"HIV Med"},{"key":"10.1016\/j.annepidem.2025.11.006_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/jac\/dkae391","article-title":"Rapid viral suppression using integrase inhibitors during acute HIV-1 infection","volume":"80","author":"McKellar","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.annepidem.2025.11.006_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2023.101151","article-title":"Use of integrase inhibitors vs protease inhibitors is associated with improved HIV viral suppression","volume":"5","author":"Kleinmann","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.annepidem.2025.11.006_bib8","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(14)60084-2","article-title":"Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study","volume":"383","author":"Clotet","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2025.11.006_bib9","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJMoa1215541","article-title":"Dolutegravir plus Abacavir\u2013Lamivudine for the treatment of HIV-1 infection","volume":"369","author":"Walmsley","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2025.11.006_bib10","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/cid\/civ193","article-title":"Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257","volume":"60","author":"Ofotokun","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annepidem.2025.11.006_bib11","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3390\/pathogens11111321","article-title":"Drug resistance to integrase strand-transfer inhibitors among HIV-1-infected adults in Guangdong, China","volume":"11","author":"Lan","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.annepidem.2025.11.006_bib12","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/QAD.0000000000001494","article-title":"Emergent drug resistance with integrase strand transfer inhibitor-based regimens","volume":"31","author":"Lepik","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.annepidem.2025.11.006_bib13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/aid.2021.0091","article-title":"Integrase inhibitor use associated with weight gain in women and incident diabetes mellitus","volume":"38","author":"Asundi","year":"2022","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.annepidem.2025.11.006_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11904-024-00708-x","article-title":"Metabolic complications associated with use of integrase strand transfer inhibitors (InSTI) for the treatment of HIV-1 infection: focus on weight changes, lipids, glucose and bone metabolism","volume":"21","author":"Savinelli","year":"2024","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.annepidem.2025.11.006_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25484","article-title":"Weight gain among treatment-na\u00efve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada","volume":"23","author":"Bourgi","year":"2020","journal-title":"J Intern AIDS Soc"},{"key":"10.1016\/j.annepidem.2025.11.006_bib16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s40506-019-00203-7","article-title":"Update on adverse effects of HIV integrase inhibitors","volume":"11","author":"Kolakowska","year":"2019","journal-title":"Curr Treat Options Infect Dis"},{"key":"10.1016\/j.annepidem.2025.11.006_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11481-021-10042-3","article-title":"Integrase inhibitors are associated with neuropsychiatric symptoms in women with HIV","volume":"18","author":"Rubin","year":"2023","journal-title":"J Neuroimmune Pharm"},{"key":"10.1016\/j.annepidem.2025.11.006_bib18","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.annepidem.2025.11.006_bib19","doi-asserted-by":"crossref","first-page":"S355","DOI":"10.1093\/infdis\/jis195","article-title":"HIV infection and coronary heart disease: an intersection of epidemics","volume":"205","author":"Triant","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.annepidem.2025.11.006_bib20","first-page":"140","article-title":"Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the american heart association","author":"Feinstein","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.annepidem.2025.11.006_bib21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/cid\/ciad286","article-title":"Impact of integrase inhibitors on cardiovascular disease events in people with human immunodeficiency virus starting antiretroviral therapy","volume":"77","author":"Surial","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annepidem.2025.11.006_bib22","doi-asserted-by":"crossref","first-page":"e723","DOI":"10.1016\/S2352-3018(23)00233-3","article-title":"Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration","volume":"10","author":"Rein","year":"2023","journal-title":"Lancet HIV"},{"key":"10.1016\/j.annepidem.2025.11.006_bib23","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/S2352-3018(22)00094-7","article-title":"Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium","volume":"9","author":"Neesgaard","year":"2022","journal-title":"Lancet HIV"},{"key":"10.1016\/j.annepidem.2025.11.006_bib24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3390\/v16040613","article-title":"Risk of cardiovascular events in people with HIV (PWH) treated with integrase strand-transfer inhibitors: the debate is not over; results of the SCOLTA study","volume":"16","author":"Corti","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.annepidem.2025.11.006_bib25","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/QAI.0000000000002357","article-title":"Brief report: integrase strand transfer inhibitors are associated with lower risk of incident cardiovascular disease in people living with HIV","volume":"84","author":"O\u2019Halloran","year":"2020","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.annepidem.2025.11.006_bib26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMsr1809937","article-title":"The \u201cAll of Us\u201d research program","volume":"381","author":"The All of Us Research Program Investigators","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2025.11.006_bib27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41591-023-02744-3","article-title":"The All of Us Research Program is an opportunity to enhance the diversity of US biomedical research","volume":"30","author":"Bianchi","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.annepidem.2025.11.006_bib28","doi-asserted-by":"crossref","first-page":"ooad071","DOI":"10.1093\/jamiaopen\/ooad071","article-title":"Computational phenotyping with the All of Us Research Program: identifying underrepresented people with HIV or at risk of HIV","volume":"6","author":"Yang","year":"2023","journal-title":"JAMIA Open"},{"key":"10.1016\/j.annepidem.2025.11.006_bib29","unstructured":"All of Us Research Hub. The All of Us Data Browser n.d. \u3008https:\/\/databrowser.researchallofus.org\/\u3009 (accessed February 25, 2025)."},{"key":"10.1016\/j.annepidem.2025.11.006_bib30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/amiajnl-2011-000116","article-title":"Normalized names for clinical drugs: RxNorm at 6 years","volume":"18","author":"Nelson","year":"2011","journal-title":"J Am Med Inf Assoc"},{"key":"10.1016\/j.annepidem.2025.11.006_bib31","article-title":"Effectiveness of integrase strand transfer inhibitors among treatment-naive people living with HIV\/AIDS in Guangdong, China: A real-world, retrospective cohort study","volume":"103","author":"Chen","year":"2024","journal-title":"Medicine"},{"key":"10.1016\/j.annepidem.2025.11.006_bib32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivar Behav Res"},{"key":"10.1016\/j.annepidem.2025.11.006_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40261-014-0266-2","article-title":"Comparative changes of lipid levels in treatment-naive, HIV-1-infected adults treated with Dolutegravir vs. Efavirenz, Raltegravir, and ritonavir-boosted darunavir-based regimens over 48 weeks","volume":"35","author":"Quercia","year":"2015","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.annepidem.2025.11.006_bib34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/QAI.0b013e318157131c","article-title":"Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study","volume":"46","author":"Markowitz","year":"2007","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.annepidem.2025.11.006_bib35","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/S0140-6736(12)60917-9","article-title":"Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks","volume":"379","author":"Sax","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2025.11.006_bib36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s12879-018-3268-5","article-title":"Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA)","volume":"18","author":"Taramasso","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.annepidem.2025.11.006_bib37","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/hiv.13273","article-title":"Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium","volume":"23","author":"Byonanebye","year":"2022","journal-title":"HIV Med"},{"key":"10.1016\/j.annepidem.2025.11.006_bib38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/toxsci\/kfz203","article-title":"Chronic nucleoside reverse transcriptase inhibitors disrupt mitochondrial homeostasis and promote premature endothelial senescence","volume":"172","author":"Chen","year":"2019","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.annepidem.2025.11.006_bib39","doi-asserted-by":"crossref","unstructured":"Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. The Lancet 2008;371:1417\u20131426. https:\/\/doi.org\/10.1016\/S0140-6736(08)60423-7.","DOI":"10.1016\/S0140-6736(08)60423-7"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279725003370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279725003370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:20:29Z","timestamp":1781238029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279725003370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":39,"alternative-id":["S1047279725003370"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2025.11.006","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of integrase strand transfer inhibitors on cardiovascular disease in people with HIV","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2025.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}